COVID-19 Testing Information and News for Individuals, Healthcare Providers, Payers, and Organizations Additional Navigation C-19 Home Individuals Providers & Payers Workplaces News & Education Let’s determine which COVID-19 test is right for you. Do I currently have COVID-19? Active Infection Test Options Did I have COVID-19 at one time? Antibody Test Options How do I find my test results? Test Result Options What are my treatment and vaccine options? Treatment & Vaccine Options PIXEL BY LABCORP Get a Labcorp At-home COVID-19 Test Collection Kit at $0 Upfront Cost. Find out if you currently have COVID-19 without leaving home. Get Started CONVENIENT COVID-19 TESTING OPTIONS Keep yourself and your loved ones safe by testing for COVID-19 With over 50 million COVID-19 tests performed since the start of the pandemic, our tests continue to detect all of the variant changes being tracked by the CDC, including the Delta variant. There are four ways to get the trusted Labcorp COVID-19 PCR test. Learn more about testing options Tracking COVID-19 Variants Labcorp has been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants. We have been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19. Total number of samples sequenced 200,000 as of October 28, 2021 Data covers the U.S. including the District of Columbia and Puerto Rico Labcorp PCR Test performance confirmed Alpha (B.1.1.7, Q.1-Q.8) Beta (B.1.351, B.1.351.2, B.1.351.3) Delta (B.1.617.2) Gamma (P.1, P.1.1, P.1.2) Epsilon (B.1.427, B.1.429) Eta (B.1.525) Iota (B.1.526) Kappa (B.1.617.1) 1.617.3 Mu (B.1.621) Zeta (P.2) Lambda (C.37) For more information visit US COVID-19 Cases Caused by Variants on the CDC website. Labcorp's COVID-19 Testing Stats 1-2 DAYS COVID-19 PCR TESTING Average Time to Result From Specimen Pickup 53.8M COVID-19 PCR TESTING Molecular Tests Performed 7.1M COVID-19 ANTIBODY TESTING Antibody Tests Performed Stats updated as of September 30, 2021. COVID-19 volumes are U.S. and Canada volumes and are consistent with the figures provided in the company’s quarterly financial results. Prior volumes published on the website were U.S. only. Future COVID-19 test volumes will be updated quarterly after the release of Labcorp’s quarterly earnings results. HOW CAN I MAKE A DIFFERENCE? COVID-19 Clinical Trials Connect Covance by Labcorp is running multiple COVID-19 research studies and invites you to help in the fight against COVID-19. Learn More GET TESTED See How Labcorp Performs the COVID-19 Test You can get tested through your healthcare provider, have them request a Labcorp COVID-19 home collection kit, or request one yourself by visiting Pixel by Labcorp™. Request At-home Collection Kit Learn More (link is external) Latest & Previous News Nov 4 2021 Labcorp And National Kidney Foundation Promote Patient Registry To Enhance Clinical Trial Accessibility, Diversity BURLINGTON, N.C., and NEW YORK, N.Y., Nov. 4, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, and the National Kidney Foundation (NKF), the largest patient organization dedicated to the prevention and treatment of kidney disease, announced their collaboration to promote the NKF Patient Network, the first national registry for chronic kidney disease (CKD) patients in the U.S. The NKF Patient Network will offer greater data and insights to physicians, as well as improved clinical trial access for patients with kidney disease. Read more » Previous News Releases and Media Statements Oct 1 2021 Labcorp Receives Emergency Use Authorization for At Home Collection Kit for Combined COVID-19 and Flu Detection BURLINGTON, N.C., October 1, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined home collection kit that detects COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age. The kit will be available at no upfront cost to those who meet clinical guidelines, which may include experiencing symptoms, being exposed to someone with COVID-19 or if asked to be tested by a health care provider. Read more » Jul 1 2021 Labcorp Extends COVID-19 Genomic Sequencing Work With The CDC BURLINGTON, N.C., June 30, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the extension of its work with the U.S. Centers for Disease Control and Prevention (CDC) to help identify and monitor variants of SARS-CoV-2, the virus that causes COVID-19. Read more » Jun 22 2021 Labcorp Adopts Molecular Loop SARS-CoV-2 Research Sequencing Panel for Large-Scale Viral Surveillance Molecular Loop Biosciences, Inc. , a company redefining the simplicity of targeted sequencing, announced today that its SARS-CoV-2 Research Sequencing Panel has been deployed by Labcorp (NYSE: LH), a leading global life sciences company, to help sequence thousands of complete coronavirus genomes each week from positive patient samples. This sequencing is being performed as part of a U.S. Centers for Disease Control and Prevention (CDC) effort to identify and track the spread of SARS-CoV-2 variants throughout the country. Read more » Jun 16 2021 NCDHHS Expands Home Testing Program to All Eligible North Carolinians The North Carolina Department of Health and Human Services today announced the state is expanding availability of its at-home COVID-19 test collection. Any North Carolina resident may receive a Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit that is shipped overnight directly to their homes at no cost. Tests can be used on people age 2 and up. Read more » May 25 2021 Labcorp Study Suggests COVID-19 Antibodies Remain at Least 10 Months After Infection BURLINGTON, N.C.--(BUSINESS WIRE)--May 24, 2021-- Nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2 proteins for at least 10 months, according to a new Labcorp (NYSE: LH) analysis of specimens from 39,086 individuals. Read more » May 13 2021 Pixel by Labcorp COVID-19 PCR Test Home Collection Kit Receives FDA Emergency Authorization for Ages 2-17 BURLINGTON, N.C., May 13, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Pixel by Labcorp COVID-19 PCR Test Home Collection Kit for ages 2-17. The authorization expands the use of Pixel by Labcorp to children and adolescents 2 years of age and older when purchased by a parent or guardian. Read more » Labcorp About Us Newsroom Careers(link is external) Investors(link is external) FAQs Labs Test Results All Patient All Provider Resources Insurers Suppliers & Vendors HIPAA Notice of Privacy Practices Quick Links Drug Development Drug Testing Paternity Testing(link is external) Pixel by Labcorp Contact Us Patient Provider LabCorp on Linkedin LabCorp on Twitter LabCorp on Facebook LabCorp on YouTube LabCorp on Instagram Legal Menu Privacy Statement Terms of Use Notice of Nondiscrimination Combatting Modern Slavery and Human Trafficking Statement © 2021 Laboratory Corporation of America® Holdings. All Rights Reserved. We use cookies to enable certain functions and tools on this website, track resources and data used on this website, and promote our products and services. We also share information about your use of our website with our analytics partners. For more information on our use of cookies, please see our Cookie Statement. Cookies Settings Accept Cookies